Telemark Asset Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$25.4M Buy
+500,000
New +$23.3M 2.35% 13
2025
Q4
Sell
-500,000
Closed -$12.9M 59
2025
Q3
$12.9M Buy
+500,000
New +$13.9M 1.23% 28
2024
Q3
Sell
-250,000
Closed -$29.7M 67
2024
Q2
$29.7M Hold
250,000
2.68% 8
2024
Q1
$26.6M Buy
+250,000
New +$25.2M 2.75% 7
2023
Q4
Sell
-200,000
Closed -$20.7M 56
2023
Q3
$20.7M Hold
200,000
3.13% 10
2023
Q2
$24.3M Buy
200,000
+50,000
+33% +$6.67M 3.3% 13
2023
Q1
$23M Sell
150,000
-150,000
-50% -$24.7M 3.42% 14
2022
Q4
$53.9M Buy
300,000
+50,000
+20% +$8.18M 8.17% 1
2022
Q3
$29.6M Buy
250,000
+60,000
+32% +$9.1M 4.64% 7
2022
Q2
$27.1M Sell
190,000
-10,000
-5% -$1.43M 4.59% 5
2022
Q1
$34.5M Sell
200,000
-50,000
-20% -$8.42M 3.04% 7
2021
Q4
$63.5M Sell
250,000
-100,000
-29% -$29.2M 4.54% 4
2021
Q3
$135M Buy
350,000
+50,000
+17% +$18.4M 9.75% 1
2021
Q2
$70.5M Buy
300,000
+65,000
+28% +$11.6M 5.63% 2
2021
Q1
$30.8M Buy
+235,000
New +$34.1M 2.61% 9

Other funds holding MRNA